Pliant Therapeutics Inc (NASDAQ: PLRX) Hogging The Spotlight Today
Currently, there are 60.85M common shares owned by the public and among those 52.66M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
Pliant Therapeutics Inc (NASDAQ: PLRX): Stock That Needs Special Handling
Currently, there are 60.85M common shares owned by the public and among those 53.50M shares have been available to trade. The company’s stock has a 5-day price change of -77.09% and -82.85% over the past three months. PLRX shares are trading -80.22% year to date (YTD), with the 12-month market performance down to -84.01% lower. […]
Pliant Therapeutics Inc (PLRX) Testing Investors’ Patience Right Now
Currently, there are 60.85M common shares owned by the public and among those 53.50M shares have been available to trade. The company’s stock has a 5-day price change of -72.54% and -80.45% over the past three months. PLRX shares are trading -76.69% year to date (YTD), with the 12-month market performance down to -80.78% lower. […]
